STRISCIUGLIO, Caterina
 Distribuzione geografica
Continente #
EU - Europa 1.379
NA - Nord America 1.030
AS - Asia 159
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
SA - Sud America 1
Totale 2.575
Nazione #
US - Stati Uniti d'America 1.028
IE - Irlanda 634
IT - Italia 208
GB - Regno Unito 167
UA - Ucraina 126
CN - Cina 107
GR - Grecia 81
DE - Germania 59
FI - Finlandia 48
TR - Turchia 39
SE - Svezia 17
FR - Francia 13
BE - Belgio 8
ES - Italia 7
RO - Romania 5
EU - Europa 4
HK - Hong Kong 3
IR - Iran 3
CA - Canada 2
CH - Svizzera 2
IN - India 2
JP - Giappone 2
NL - Olanda 2
VN - Vietnam 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
Totale 2.575
Città #
Dublin 632
Jacksonville 247
Chandler 146
Roxbury 89
Princeton 87
Beijing 67
Medford 63
Ann Arbor 40
Cambridge 28
Des Moines 26
Naples 24
Wilmington 24
Napoli 22
Woodbridge 22
Caserta 19
Bremen 16
Mountain View 13
Redwood City 10
Lappeenranta 9
Ashburn 8
Brussels 8
Nanchang 7
Pagani 7
Rome 7
Boardman 6
Düsseldorf 6
New York 6
Battipaglia 5
Helsinki 5
Konya 5
Munich 5
Nanjing 5
Auburn Hills 4
Hebei 4
Lanzhou 4
Jinan 3
Kunming 3
Milan 3
Amsterdam 2
Berlin 2
Brescia 2
Campbell 2
Cercola 2
Dong Ket 2
Dresden 2
Frankfurt Am Main 2
Grumo Nevano 2
Haikou 2
Memphis 2
Nagasaki 2
Newark 2
Norwalk 2
Orta di Atella 2
Seattle 2
Tianjin 2
West Jordan 2
Wettingen 2
Zhengzhou 2
Barcelona 1
Bonea 1
Borås 1
Büdingen 1
Casaluce 1
Changchun 1
Changsha 1
Cherry Hill 1
Dearborn 1
Durham 1
Fairmount 1
Foggia 1
Giugliano In Campania 1
Guadalajara 1
Gunzenhausen 1
Hefei 1
Hennef 1
Mcallen 1
Messina 1
Mumbai 1
Ningbo 1
Oliveto Citra 1
Olomouc 1
Oviedo 1
Padova 1
Padula 1
Palmerton 1
Piacenza 1
Pompei 1
Pune 1
Redmond 1
Rockville 1
Salerno 1
San Giovanni Rotondo 1
San Nicola la Strada 1
Scottsdale 1
Selargius 1
São José dos Campos 1
Taipei 1
Taiyuan 1
Tostedt 1
Tregnago 1
Totale 1.767
Nome #
PROBIOTICS AND ALLERGIC RESPIRATORY DISEASES 56
Vitamin D Immunomodulatory Aspects 55
Gene expression profile of peripheral blood monocytes: a step towards the molecular diagnosis of celiac disease? 54
A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children with Irritable Bowel Syndrome 49
Yersinia Enterocolitica Ileitis Mimicking Pediatric Crohn's Disease 49
MIB2 variants altering NOTCH signalling result in left ventricle hypertrabeculation/non-compaction and are associated with Menetrier-like gastropathy 48
Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. 47
Autosomal Dominant Menetrier-like Disease 46
Serum Hepcidin and Iron Absorption in Pediatric Inflammatory Bowel Disease. 46
PP-6 BOLUS CLEARANCE TIME IS ASSOCIATED WITH REFLUX SEVERITY AND IT IS INVERSELY CORRELATED TO BASELINE IMPEDANCE VALUES IN ADOLESCENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 46
Anti-TNFα Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure 45
Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis? 43
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases 43
T regulatory cell as potential targets for immunotherapy in IBD 42
Clostridium difficile and pediatric inflammatory bowel disease: A prospective, comparative, multicenter, ESPGHAN study 42
Genetic sharing and heritability of paediatric age of onset autoimmune diseases 42
Bifidobacteria enhance antigen sampling and processing by dendritic cells in pediatric inflammatory bowel disease 42
P046 Effects of CB2 and TRPV1 stimulation on osteoclast overactivity induced by iron in pediatric inflammatory bowel disease 41
The DMT1 IVS4+44C>A polymorphism and the risk of iron deficiency anemia in children with celiac disease 40
Functional gastrointestinal disorders in migrainous children: efficacy of flunarizine 39
null 39
INTERLEUKIN-10 RECEPTOR DOWN-EXPRESSION IN EARLY-ONSET INFLAMMATORY BOWEL DISEASE: A CASE REPORT 38
Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis 38
Natural history of pancreatic involvement in paediatric inflammatory bowel disease 37
Nigrostriatal involvement in Ataxia with oculomotor Apraxia Type I 34
T300A Variant of Autophagy ATG16L1 Gene is Associated with Decreased Antigen Sampling and Processing by Dendritic Cells in Pediatric Crohn?s Disease 34
The Changing Face of Pediatric Ulcerative Colitis: A Population-based Cohort Study 34
Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease 34
Impact of malnutrition on gastrointestinal disorders and gross motor abilities in children with cerebral palsy 33
Different serum enzyme levels are required for the rescue of the various systemic features in mucopolysaccharidoses 33
The Role of Inflammation on Vitamin D Levels in a Cohort of Pediatric Patients With Inflammatory Bowel Disease 33
Black oesophagus in an adolescent with type 2 diabetes 33
The pediatric endoscopy practice in Italy: A nationwide survey on behalf of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP) 32
Effectiveness of Mediterranean Diet’s Adherence in Children with Inflammatory Bowel Diseases 32
Impaired autophagy leads to abnormal dendritic cell-epithelial cell interactions 31
Periappendiceal inflammation in pediatric ulcerative colitis. 31
Non-invasive repetitive imaging of somatostatin receptor 2 gene transfer with positron emission tomography 31
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 31
Autophagy genes variants and paediatric Crohn's disease phenotype: A single-centre experience 30
Mechanisms of gastroesophageal reflux in children with sequelae of birth asphyxia 30
Impact of Environmental and Familial Factors in a Cohort of Pediatric Patients with Inflammatory Bowel Disease 30
Antibiotic Prophylaxis for Percutaneous Endoscopic Gastrostomy in Children: A Randomised Controlled Trial 30
Increased expression of CB2 receptor in the intestinal biopsies of children with inflammatory bowel disease 29
Use of biosimilars in paediatric inflammatory bowel disease: A position statement of the ESPGHAN paediatric IBD porto group 28
NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease 28
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study 28
Effect of 2-hydroxyethyl methacrylate on human pulp cell survival pathways ERK and AKT 27
Growth Hormone receptor gene expression increase reflects nutritional status improvement in patients affected by Crohn's disease 27
Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic 27
Sleep and temperature rhythms in two sisters with P102L Gerstmann-Sträussler-Scheinker (GSS) disease 26
Development of A Core Outcome Set For Infant Gastroesophageal Reflux Disease 26
Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition 26
Effects of CB2 and TRPV1 stimulation on osteoclast overactivity induced by iron in pediatric inflammatory bowel disease 26
Celiac disease in pediatric patients according to HLA genetic risk classes: a retrospective observational study 25
Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: A multicentre study 25
Corrigendum to: Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study 25
The Role of Inflammation in the Endothelial Dysfunction in a Cohort of Pediatric Patients with Inflammatory Bowel Disease 24
Prevalence of functional gastrointestinal disorders in children with celiac disease during the COVID-19 lockdown 24
Exclusive enteral nutrition effect on the clinical course of pediatric Crohn’s disease: a single center experience 24
A Core Outcome Set for Clinical Trials in Pediatric Functional Abdominal Pain Disorders 23
The potential use of gene expression profile to identify useful biomarkers for the diagnosis and the treatment of pediatric inflammatory bowel diseases 23
Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study 22
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition 22
Functional chronic constipation: Rome III criteria versus Rome IV criteria 22
Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN 22
Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN 22
Foreign body and caustic ingestions in children: A clinical practice guideline 22
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease 22
Cyclic Vomiting Syndrome in Children 22
Long-term Outcomes of Paediatric Patients Admitted with Acute Severe Colitis - A Multicenter Study from the Paediatric IBD Porto Group of ESPGHAN 21
Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition 20
Pouchitis in pediatric ulcerative colitis: A multicenter study on behalf of Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition 20
Anorectal Manometry in Children: The Update on the Indications and the Protocol of the Procedure 19
Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP) 19
The Role of Cannabinoid Receptor Type 2 in the Bone Loss Associated with pediatric Celiac Disease 19
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease 18
Corrigendum: Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 18
Overall Impact of Coronavirus Disease 2019 Outbreak in Children With Functional Abdominal Pain Disorders: Results From the First Pandemic Phase 17
Functional Gastrointestinal Disorders in Mediterranean Countries According to Rome IV Criteria 16
Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry 15
Improvement of body composition and bone mineral density after enteral nutrition in pediatric Crohn disease 15
Role of Vitamin D in Celiac Disease and Inflammatory Bowel Diseases 15
Role of inflammation in pediatric irritable bowel syndrome 14
Differences in Management of Eosinophilic Esophagitis in Europe: An Assessment of Current Practice 14
Increased frequency of regulatory T cells in pediatric inflammatory bowel disease at diagnosis: a compensative role? 14
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group 14
Fever of unknown origin: Diagnostic approach through a clinical case 14
Faecal calprotectin and ultrasonography as non-invasive screening tools for detecting colorectal polyps in children with sporadic rectal bleeding: A prospective study 13
Diet and Pediatric Functional Gastrointestinal Disorders in Mediterranean Countries 12
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y) 12
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group 12
Training Opportunities in Data Science Are Welcome in ESPGHAN: A Survey on Behalf of the Special Interest Group for Basic Science and Translational Research 11
Disease-associated DNA methylation signatures in esophageal biopsies of children diagnosed with Eosinophilic Esophagitis 11
Promelaxin Microenemas Are Non-inferior to Oral Polyethylene Glycol for the Treatment of Functional Constipation in Young Children: A Randomized Clinical Trial 11
Management of infants with brief resolved unexplained events (Brue) and apparent life-threatening events (alte): A rand/ucla appropriateness approach 11
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group 11
Isolated intestinal Ganglioneuromatosis: case report and literature review 10
Esophagogastroduodenoscopy and ileocolonoscopy 10
Outcomes Following Pouch Formation in Paediatric Ulcerative Colitis: A Study From the Porto Group of ESPGHAN 9
Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease During COVID-19 Pandemic: A Prospective Study 8
Totale 2.753
Categoria #
all - tutte 14.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.359


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 8 2
2019/2020310 52 38 3 4 85 7 60 10 23 16 11 1
2020/2021369 2 5 39 63 49 6 60 35 3 23 81 3
2021/2022545 1 1 1 38 163 5 27 11 11 64 31 192
2022/2023881 121 40 19 33 37 64 7 19 514 4 10 13
2023/2024340 30 12 10 14 168 16 16 9 11 54 0 0
Totale 2.839